Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Rangering i aksjer #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Aksjekurs
$5.59
Sist synkronisert: 2026-09-02
Markedsverdi
$205.21M
Endring (1 dag)
6.27%
Endring (1 år)
86.33%
Land
US
Handel Armata Pharmaceuticals, Inc. (ARMP)

Kategori

Historikk for aksjesplitt for Armata Pharmaceuticals, Inc. (ARMP)
Aksjen Armata Pharmaceuticals, Inc. (symbol: ARMP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 03, 2026.
Én ARMP-aksje kjøpt før Sep 03, 2026 tilsvarer i dag 0 ARMP-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH